Advertisement

Current status and perspectives of brachytherapy for breast cancer

  • Csaba Polgár
  • Tibor Major
Review Article
First Online:

Abstract

Before the era of breast-conserving therapy, brachytherapy implants were used to treat large inoperable breast tumors. In later years, interstitial brachytherapy with rigid needles or multiple flexible catheters has been used to deliver an additional (boost) dose to the tumor bed after breast-conserving surgery and whole-breast irradiation. Reexcision followed by reirradiation using interstitial breast implants has also been implemented as an alternative to mastectomy to treat ipsilateral breast local recurrence after previous breast-conserving therapy. In the past two decades, the new concept of accelerated partial breast irradiation opened a new perspective for breast brachytherapy. The first technique utilized in early accelerated partial breast irradiation studies was multicatheter interstitial brachytherapy. Beyond classical interstitial brachytherapy, recently, new intracavitary applicators have been developed in the United States to decrease the existing barriers against the widespread use of multicatheter brachytherapy. Furthermore, interstitial low-dose-rate seed implants have also been implemented as an alternative for stepping-source multicatheter brachytherapy. In this article, we give an overview of the past achievements, current status, and future perspectives of breast brachytherapy.

Key words

Breast cancer Brachytherapy Local recurrence Tumor bed boost Accelerated partial breast irradiation 
This is a preview of subscription content, log in to check access.

References

  1. 1.
    Keynes G (1929) The treatment of primary carcinoma of the breast with radium. Acta Radiol 10:393–402CrossRefGoogle Scholar
  2. 2.
    Forquet A, Campana F, Mosseri V, et al. (1995) Iridium-192 versus cobalt-60 boost in 3–7 cm breast cancer treated by irradiation alone: final results of a randomized trial. Radiother Oncol 34:114–120CrossRefGoogle Scholar
  3. 3.
    Polgár C, Fodor J, Major T, et al. (2001) The role of boost irradiation in the conservative treatment of stage I-II breast cancer. Pathol Oncol Res 7:241–250PubMedGoogle Scholar
  4. 4.
    Van Limbergen E (2007) Indications and technical aspects of brachytherapy in breast conserving treatment of breast cancer. Cancer Radiother 7:107–120Google Scholar
  5. 5.
    Kuerer HM, Arthur DW, Haffty BG (2004) Repeat breastconserving surgery for in-breast local breast carcinoma recurrence: the potential role of partial breast irradiation. Cancer 100:2269–2280PubMedCrossRefGoogle Scholar
  6. 6.
    Polgár C, Strnad V, Major T (2005) Brachytherapy for partial breast irradiation: the European experience. Semin Radiat Oncol 15:116–122PubMedCrossRefGoogle Scholar
  7. 7.
    Vicini FA, Arthur W (2005) Breast brachytherapy: North American experience. Semin Radiat Oncol 15:108–115PubMedCrossRefGoogle Scholar
  8. 8.
    Cionini L, Marzano S, Pacini P, et al. (1995) Iridium implant of the surgical bed as the sole radiotherapeutic treatment after conservative surgery for breast cancer (abstract). Radiother Oncol 35(Suppl):S1Google Scholar
  9. 9.
    Fentiman IS, Poole C, Tong PJ, et al. (1991) Iridium implant treatment without external radiotherapy for operable breast ancer: a pilot study. Eur J Cancer 27:447–450PubMedCrossRefGoogle Scholar
  10. 10.
    Fentiman IS, Poole C, Tong D, et al. (1996) Inadequacy of iridium implant as a sole radiation treatment for operable breast cancer. Eur J Cancer 32A:608–611PubMedCrossRefGoogle Scholar
  11. 11.
    Fentiman IS, Deshmane V, Tong D, et al. (2004) Caesium137 implant as sole radiation therapy for operable breast cancer: a phase II trial. Radiother Oncol 71:281–285PubMedCrossRefGoogle Scholar
  12. 12.
    King TA, Bolton JS, Kuske RR, et al. (2000) Long-term results of wide-field brachytherapy as the sole method of radiation therapy after segmental mastectomy for Tis,1,2 breast cancer. Am J Surg 180:299–304PubMedCrossRefGoogle Scholar
  13. 13.
    Perera F, Yu E, Engel J, et al. (2003) Patterns of breast recurrence in a pilot study of brachytherapy confined to the lumpectomy site for early breast cancer with 6 years’ minimum follow-up. Int J Radiat Oncol Biol Phys. 57:1239–1246PubMedGoogle Scholar
  14. 14.
    Polgár C, Sulyok Z, Fodor J, et al. (2002) Sole brachytherapy of the tumor bed after conservative surgery for T1 breast cancer: 5-year results of a phase I-II study and initial findings of a randomized phase III trial. J Surg Oncol 80:121–128PubMedCrossRefGoogle Scholar
  15. 15.
    Vicini FA, Baglan KL, Kestin LL, et al. (2001) Accelerated treatment of breast cancer. J Clin Oncol 19:1993–2001PubMedGoogle Scholar
  16. 16.
    Chen PY, Vicini FA, Benitez P, et al. (2006). Long-term cosmetic results and toxicity after accelerated partial-breast irradiation — a method of radiation delivery by interstitial brachytherapy for the treatment of early-stage breast carcinoma. Cancer 106:991–999PubMedCrossRefGoogle Scholar
  17. 17.
    Johansson B, Karlsson L, Liljegren G, et al. (2008) Pulsed dose rate brachytherapy as the sole adjuvant radiotherapy after breastconserving surgery of T1-T2 breast cancer: first long time results from a clinical study. Radiother Oncol doi:10.1016/j.radonc.2008. 02.022 (2008)Google Scholar
  18. 18.
    Ott OJ, Hildebrandt G, Pötter R, et al. (2007) Accelerated partial breast irradiation with multi-catheter brachytherapy: local control, side effects and cosmetic outcome for 274 patients. Results of the German-Austrian multi-centre trial. Radiother Oncol 82:281–286PubMedCrossRefGoogle Scholar
  19. 19.
    Polgár C, Fodor J, Major T, et al. (2007) Breast-conserving treatment with partial or whole breast irradiation for low-risk invasive breast carcinoma — 5-year results of a randomized trial. Int J Radiat Oncol Biol Phys 69:694–702PubMedGoogle Scholar
  20. 20.
    Polgár C, Major T, Fodor J, et al. (2004) HDR brachytherapy alone versus whole breast radiotherapy with or without tumor bed boost after breast conserving surgery: 7-year results of a comparative study. Int J Radiat Oncol Biol Phys 60:1173–1181PubMedGoogle Scholar
  21. 21.
    Vicini FA, Antonucci V, Wallace M, et al. (2007) Long-term efficacy and patterns of failure after accelerated partial breast irradiation: a molecular assay-based clonality evaluation. Int J Radiat Oncol Biol Phys 68:341–346PubMedGoogle Scholar
  22. 22.
    Beriwal S, Coon D, Kim H, et al. (2008) Multicatheter hybrid breast brachytherapy: a potential alternative for patients with inadequate skin distance. Brachytherapy 7:301–304PubMedCrossRefGoogle Scholar
  23. 23.
    Dickler A, Seif N, Kirk MC, et al. (2008) A dosimetric comparison of MammoSite and ClearPath high-dose-rate breast brachytherapy devices. Brachytherapy doi:10.1016/j.brachy.2008.07.006 (In press)Google Scholar
  24. 24.
    Edmundson GK, Vicini F, Chen P, et al. (2002) Dosimetric characteristics of the MammoSite® RTS, a new breast brachytherapy applicator. Int J Radiat Oncol Biol Phys 4:1132–1139Google Scholar
  25. 25.
    Scanderbeg DJ, Yashar C, Rice R, et al. (2008) Clinical implementation of a new HDR brachytherapy device for partial breast irradiation. Radiother Oncol doi:10.1016/j.radonc.2008.09.024 (In press)Google Scholar
  26. 26.
    Pignol JP, Keller B, Rakovitch E, et al. (2006) First report of permanent breast 103Pd seed implant as adjuvant radiation treatment for early-stage breast cancer. Int J Radiat Oncol Biol Phys 64:176–181PubMedGoogle Scholar
  27. 27.
    NIH Consensus Conference (1991) Treatment of early-stage breast cancer. JAMA 265:391–395CrossRefGoogle Scholar
  28. 28.
    Bartelink H, Horiot JC, Poortmans H, et al. (2007) Impact of a higher radiation dose on local control and survival in breastconserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial. J Clin Oncol 25:3259–3265PubMedCrossRefGoogle Scholar
  29. 29.
    Polgár C, Fodor J, Orosz Z, et al. (2002) Electron and high dose rate brachytherapy boost in the conservative treatment of stage I-II breast cancer: first results of the randomized Budapest boost trial. Strahlenther Onkol 178:615–623PubMedCrossRefGoogle Scholar
  30. 30.
    Polgár C, Fodor J, Orosz Z, et al. (2002) Electron and brachytherapy boost in the conservative treatment of stage I-II breast cancer: 5-year results of the randomized Budapest boost trial (Abstract). Radiother Oncol 64(Suppl 1):S15Google Scholar
  31. 31.
    Romestaing P, Lehingue Y, Carrie C, et al. (1997) Role of a 10-Gy boost in the conservative treatment of early breast cancer: results of a randomized clinical trial in Lyon, France. J Clin Oncol 15:963–968PubMedGoogle Scholar
  32. 32.
    Mansfield CM, Komarnicky LT, Schwartz GF, et al. (1995) Tenyear results in 1070 patients with stages I and II breast cancer treated by conservative surgery and radiation therapy. Cancer 75:2328–2336PubMedCrossRefGoogle Scholar
  33. 33.
    Moreno F, Guedea F, Lopez J, et al. (2000) External beam irradiation plus 192Ir implant after breast-preserving surgery in women with early breast cancer. Int J Radiat Oncol Biol Phys 48:757–765PubMedGoogle Scholar
  34. 34.
    Perez CA, Taylor ME, Halverson K, et al. (1996) Brachytherapy or electron beam boost in conservation therapy of carcinoma of the breast: a nonrandomized comparison. Int J Radiat Oncol Biol Phys. 34:995–1007PubMedGoogle Scholar
  35. 35.
    Touboul E, Belkacemi Y, Lefranc JP, et al. (1995) Early breast cancer: influence of type of boost (electron vs iridium-192 implant) on local control and cosmesis after conservative surgery and radiation therapy. Radiother Oncol 34:105–113PubMedCrossRefGoogle Scholar
  36. 36.
    Vicini FA, Horwitz EM, Lacerna MD, et al. (1997) Longterm outcome with interstitial brachytherapy in the management of patients with early-stage breast cancer treated with breastconserving therapy. Int J Radiat Oncol Biol Phys 37:845–852PubMedGoogle Scholar
  37. 37.
    Wazer DE, Kramer B, Schmid C, et al. (1997) Factors determining outcome in patients treated with interstitial implantation as a radiation boost for breast conservation therapy. Int J Radiat Oncol Biol Phys 39:381–393PubMedGoogle Scholar
  38. 38.
    Henriquez I, Guix B, Tello JI, et al. (2001) Long term results of high-dose-rate (HDR) brachytherapy boost in preserving-breast cancer patients: the experience of Radiation Oncology Medical Institute (IMOR) of Barcelona (abstract). Radiother Oncol 60(Suppl 1):S11CrossRefGoogle Scholar
  39. 39.
    Resch A, Pötter R, Van Limbergen E, et al. (2002) Long-term results (10 years) of intensive breast conserving therapy including a high-dose and large-volume interstitial brachytherapy boost (LDR/PDR) for T1/T2 breast cancer. Radiother Oncol 63:47–58PubMedCrossRefGoogle Scholar
  40. 40.
    Neumanova R, Petera J, Frgala T, et al. (2008) Long-term outcome with interstitial brachytherapy boost in the treatment of women with early-stage breast cancer. Neoplasma 54:413–423Google Scholar
  41. 41.
    Hammer J, Seewald DH, Track C, et al. (1994) Breast cancer: primary treatment with external-beam radiation therapy and high-dose-rate iridium implantation. Radiology 193:573–577PubMedGoogle Scholar
  42. 42.
    Jacobs H (1992) HDR afterloading experience in breast conservation therapy. Selectron Brachytherapy Journal 6:14–17Google Scholar
  43. 43.
    Budrukkar AN, Sarin R, Shrivastava SK, et al. (2007) Cosmesis, late sequelae and local control after breast-conserving therapy: influence of type of tumour bed boost and adjuvant chemotherapy. Clin Oncol 19:596–603CrossRefGoogle Scholar
  44. 44.
    Guinot JL, Roldan S, Maronas M, et al. (2007) Breast-conservative surgery with close or positive margins: can the breast be preserved with high-dose-rate brachytherapy boost? Int J Radiat Oncol Biol Phys 68:1381–1387PubMedGoogle Scholar
  45. 45.
    Hennequin C, Durdux C, Espié M, et al. (1999) High-dose-rate brachytherapy for early breast cancer: an ambulatory technique. Int J Radiat Oncol Biol Phys 45:85–90PubMedGoogle Scholar
  46. 46.
    Polgár C, Jánváry L, Major T, et al. (2007) The role of high-doserate (HDR) brachytherapy boost in breast-conserving therapy: 10-year Hungarian experience (abstract). Radiother Oncol 83(Suppl 1):S22Google Scholar
  47. 47.
    Knauerhase H, Strietzel M, Gerber B, et al. (2008) Tumor location, interval between surgery and radiotherapy, and boost technique influence local control after breast-conserving surgery and radiation: retrospective analysis of monoinstitutional long-term results. Int J Radiat Oncol Biol Phys 72:1048–1055PubMedGoogle Scholar
  48. 48.
    Manning MA, Arthur DW, Schmidt-Ullrich RK, et al. (2000) Interstitial high-dose-rate brachytherapy boost: the feasibility and cosmetic outcome of a fractionated outpatient delivery scheme. Int J Radiat Oncol Biol Phys 48:1301–1306PubMedGoogle Scholar
  49. 49.
    Poortmans P, Bartelink H, Horiot JC, et al. (2004) The influence of the boost technique on local control in breast conserving treatment in the EORTC boost versus no boost randomised trial. Radiother Oncol 72:25–33PubMedCrossRefGoogle Scholar
  50. 50.
    Poortmans P, Bartelink H, Horiot JC, et al. (2008) The influence of the boost technique on local control and fibrosis after breast conserving treatment: results of the EORTC (abstract). Radiother Oncol 88(Suppl 2):S102Google Scholar
  51. 51.
    Morrow M. Rational local therapy for breast cancer (2002) New Engl J Med 347:1270–1271PubMedCrossRefGoogle Scholar
  52. 52.
    Veronesi U, Cascinelli N, Mariani L, et al. (2002) Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. New Engl J Med 347:1227–1232PubMedCrossRefGoogle Scholar
  53. 53.
    Alzieu C, Hannoun-Levi J, Ellis S, et al. (2001) Second conservative treatments for local recurrences in breast cancer: feasibility and results (abstract). Int J Radiat Oncol Biol Phys 51(Suppl 1):S8Google Scholar
  54. 54.
    Hannoun-Levi JM, Houvenaeghel G, Ellis S, et al. (2004) Partial breast irradiation as second conservative treatment for local breast cancer recurrence. Int J Radiat Oncol Biol Phys 60:1385–1392PubMedGoogle Scholar
  55. 55.
    Chadha M, Feldman S, Boolbol S, et al. (2008) The feasibility of a second lumpectomy and breast brachytherapy for localized cancer in a breast previously treated with lumpectomy and radiation therapy for breast cancer. Brachytherapy 7:22–28PubMedCrossRefGoogle Scholar
  56. 56.
    Maulard C, Housset M, Brunel P, et al. (1995) Use of perioperative or split-course interstitial brachytherapy techniques for salvage irradiation of isolated local recurrences after conservative management of breast cancer. Am J Clin Oncol 18:348–352PubMedCrossRefGoogle Scholar
  57. 57.
    Resch A, Fellner C, Mock U, et al. (2002) Locally recurrent breast cancer: pulsed dose rate brachytherapy for repeat irradiation following lumpectomy — a second chance to preserve the breast. Radiology 225:713–718PubMedCrossRefGoogle Scholar
  58. 58.
    Polgár C, Major T, Fodor J, et al. (2002) Reirradiation in the treatment of local recurrence developing after previous breast conserving surgery and tele- or brachytherapy (abstract). Radiother Oncol 63(Suppl1):S6Google Scholar
  59. 59.
    Polgár C, Sulyok Z, Major T, et al. (2000) Reexcision and perioperative brachytherapy in the treatment of local relapse after breast conservation: a possible alternative to mastectomy (in Hungarian). Hungarian Surgery 53:120–123Google Scholar
  60. 60.
    Guix B, Henriquez I, Tello JI, et al. (2003) Second conservative treatment as salvage treatment for local recurrences of the breast: 12-year results from a pilot study (abstract). Radiother Oncol 66(Suppl 1):S15Google Scholar
  61. 61.
    Póti Z, Nemeskéri C, Fekésházy A, et al. (2004) Partial breast irradiation with interstitial 60Co brachytherapy results in frequent grade 3 or 4 toxicity: evidence based on a 12-year follow-up of 70 patients. Int J Radiat Oncol Biol Phys 58:1022–1033PubMedGoogle Scholar
  62. 62.
    Clarke DH, Vicini F, Jacobs H, et al. (1994) High dose rate brachytherapy for breast cancer. In: Nag S (ed) High dose rate brachytherapy: a textbook. Futura Publishing, Armonk-New York, pp 321–329Google Scholar
  63. 63.
    Polgár C, Major T, Strnad V, et al. (2004) What can we conclude from the results of an out-of-date breast-brachytherapy study? (letter) Int J Radiat Oncol Biol Phys 60:342–343PubMedCrossRefGoogle Scholar
  64. 64.
    Vicini FA, Arthur DW, Edmundson G (2004) In regard to Póti et al. (letter). Int J Radiat Oncol Biol Phys 60:345PubMedCrossRefGoogle Scholar
  65. 65.
    Vicini F., Arthur D., Polgár C., et al. (2003) Defining the efficacy of accelerated partial breast irradiation: the importance of proper patient selection, adequate quality assurance and common sense (editorial). Int J Radiat Oncol Biol Phys 57:1210–1213PubMedGoogle Scholar
  66. 66.
    Pierquin B, Dutreix A, Paine CH, et al. (1978) The Paris system in interstitial radiation therapy. Acta Radiol Oncol 17:33–48CrossRefGoogle Scholar
  67. 67.
    Polgár C, Major T, Lövey K, et al. (2008) Hungarian experience on partial breast irradiation versus whole breast irradiation: 12-year results of a phase II trial and updated results of a randomized study (abstract). Brachytherapy 7:91–92CrossRefGoogle Scholar
  68. 68.
    Kaufman SA, DiPetrillo TA, Price LL, et al. (2007) Long-term outcome and toxicity in a phase I/II trial using high-dose-rate multicatheter interstitial brachytherapy for T1/T2 breast cancer. Brachytherapy 6:286–292PubMedCrossRefGoogle Scholar
  69. 69.
    Arthur DW, Winter K, Kuske RR, et al. (2008) A phase II trial of brachytherapy alone after lumpectomy for select breast cancer: tumor control and survival outcomes of RTOG 95-17. Int J Radiat Oncol Biol Phys 72:467–473PubMedGoogle Scholar
  70. 70.
    Samuel LM, Dewar JA, Preece PE, et al. (1999) A pilot study of radical radiotherapy using a perioperative implant following wide local excision for carcinoma of the breast. Breast 8:95–97CrossRefGoogle Scholar
  71. 71.
    Gómez-Iturriaga A, Pina L, Cambeiro M, et al. (2008) Early breast cancer treated with conservative surgery, adjuvant chemotherapy, and delayed accelerated partial breast irradiation with high-dose-rate brachytherapy. Brachytherapy 7:310–315PubMedCrossRefGoogle Scholar
  72. 72.
    Nose T, Komoike Y, Yoshida K, et al. (2006) A pilot study of wider use of accelerated partial breast irradiation: intraoperative margin-directed re-excision combined with sole high-dose-rate interstitial brachytherapy. Breast Cancer 13:289–299PubMedCrossRefGoogle Scholar
  73. 73.
    Patel RR, Christensen ME, Hodge C, et al. (2008) Clinical outcome analysis in “high-risk” versus “low-risk” patients eligible for National Surgical Adjuvant Breast and Bowel B-39/Radiation Therapy Oncology Group 0413 trial: 5-year results. Int J Radiat Oncol Biol Phys 70:970–973PubMedGoogle Scholar
  74. 74.
    Krishnan L, Jewell WR, Tawfik OW, et al. (2001) Breast conservation therapy with tumor bed irradiation alone in a selected group of patients with stage I breast cancer. Breast J 7:91–96PubMedCrossRefGoogle Scholar
  75. 75.
    Slampa P, Ruzickova J, Ondrova B, et al. (2008) Sole conformal perioperative interstitial brachytherapy of early stage breast carcinoma using high-dose-rate afterloading: longer-term results and toxicity. Reports Pract Oncol Radiother 13:62–68Google Scholar
  76. 76.
    Arthur DW, Koo D, Zwicker RD, et al. (2003) Partial breast brachytherapy after lumpectomy: low-dose-rate and high-doserate experience. Int J Radiat Oncol Biol Phys 56:681–689PubMedGoogle Scholar
  77. 77.
    Yoshida K, Nose T, Masuda N, et al. (2008) Preliminary result of accelerated partial breast irradiation after breast-conserving surgery. Breast Cancer doi:10.1007/s12282-008-0067-7 (In press)Google Scholar
  78. 78.
    Aristei C, Palumbo I, Cucciarelli F, et al. (2008) Partial breast irradiation with interstitial high-dose-rate brachytherapy in early breast cancer: results of a phase II prospective study. Radiother Oncol doi:10.1016/j.ejso.2008.06.002 (In press)Google Scholar
  79. 79.
    Lawenda BD, Taghian AG, Kachnic LA, et al. (2003) Dosevolume analysis of radiotherapy for T1N0 invasive breast cancer treated by local excision and partial breast irradiation by lowdose-rate interstitial implant. Int J Radiat Oncol Biol Phys. 56:671–680PubMedGoogle Scholar
  80. 80.
    Lövey K, Fodor J, Major T, et al. (2007) Fat necrosis after partialbreast irradiation with brachytherapy or electron irradiation versus standard whole-breast radiotherapy — 4-year results of a randomized trial. Int J Radiat Oncol Biol Phys 69:724–731PubMedGoogle Scholar
  81. 81.
    Benitez PR, Keisch ME, Vicini F, et al. (2007) Five-year results: the initial clinical trial of Mammosite balloon brachytherapy for partial breast irradiation in early-stage breast cancer. Am J Surg 194:456–462PubMedCrossRefGoogle Scholar
  82. 82.
    Chao KK, Vicini FA, Wallace M, et al. (2007) Analysis of treatment efficacy, cosmesis, and toxicity using the MammoSite breast brachytherapy catheter to deliver accelerated partial-breast irradiation: the William Beaumont Hospital experience. Int J Radiat Oncol Biol Phys 69:32–40PubMedGoogle Scholar
  83. 83.
    Chen S, Dickler A, Kirk M, et al. (2007) Patterns of failure after MammoSite brachytherapy partial breast irradiation: a detailed analysis. Int J Radiat Oncol Biol Phys 69:25–31PubMedGoogle Scholar
  84. 84.
    Cuttino LW, Keisch M, Jenrette JM, et al. (2008) Multiinstitutional experience using the MammoSite Radiation Therapy System in the treatment of early-stage breast cancer: 2-year results. Int J Radiat Oncol Biol Phys Biol 71:107–114Google Scholar
  85. 85.
    Dragun AE, Harper JL, Jenrette JM, et al. (2007) Predictors of cosmetic outcome following MammoSite breast brachytherapy: a single-institution experience of 100 patients with 2 years of followup. Int J Radiat Oncol Biol Phys 68:354–358PubMedGoogle Scholar
  86. 86.
    Haley M, Beriwal S, Heron DE, et al. (2008) MammoSite accelerated partial breast irradiation: a single-institution outcomes analysis with 2 years of follow-up. Brachytherapy doi:10.1016/j. brachy.2008.07.005 (In press)Google Scholar
  87. 87.
    Vicini FA, Beitsch PD, Quiet CA, et al. (2008) Three-year analysis of treatment efficacy, cosmesis, and toxicity by the American Society of Breast Surgeons MammoSite Breast Brachytherapy Registry Trial in patients treated with accelerated partial breast irradiation (APBI). Cancer 112:758–766PubMedCrossRefGoogle Scholar
  88. 88.
    Belkacémi Y, Cauvet MP, Giard S, et al. (2008) Partial breast irradiation as sole therapy for low risk breast carcinoma: early toxicity, cosmesis and quality of life results of a MammoSite brachytherapy phase II study. Radiother Oncol doi:10.1016/j.radonc.2008.06.004 (In press)Google Scholar
  89. 89.
    Major T, Niehoff P, Kovács G, et al. (2006) Dosimetric comparisons between high dose rate interstitial and MammoSite balloon brachytherapy for breast cancer. Radiother Oncol 79:321–328PubMedCrossRefGoogle Scholar
  90. 90.
    Niehoff P, Ballardini B, Polgár C, et al. (2006) Early European experience with the MammoSite Radiation Therapy System for partial breast brachytherapy following breast conservation operation at low risk breast cancer. Breast 15:319–325PubMedCrossRefGoogle Scholar
  91. 91.
    Niehoff P, Polgár C, Ostertag H, et al. (2006) Clinical experience with the MammoSite? Radiation Therapy System for intracavitary brachytherapy of breast cancer — results from an international phase II trial. Radiother Oncol 79:316–320PubMedCrossRefGoogle Scholar
  92. 92.
    Niehoff P, Polgár C, Kovács G (2006) In regard to Belkacémi and Vicini: high-dose brachytherapy using the MammoSite applicator” … Give me your hand, and let the subject see, to make them know”. Radiother Oncol 82:355–356CrossRefGoogle Scholar
  93. 93.
    Arthur DW, Vicini FA, Kuske RR, et al. (2003) Accelerated partial breast irradiation: an updated report from the American Brachytherapy Society. Brachytherapy 2:124–130PubMedCrossRefGoogle Scholar
  94. 94.
    Hennequin C, Mazeron JJ, Chotin G (2001) How to use the Paris system in the year 2001? Radiother Oncol 58:5–6PubMedCrossRefGoogle Scholar
  95. 95.
    Polgár C, Major T, Somogyi A, et al. (2002) CT-image based conformal brachytherapy of breast cancer: the significance of semi-3D and 3D treatment planning. Strahlenther Onkol 176:118–124CrossRefGoogle Scholar
  96. 96.
    Vicini FA, Jaffray DA, Horwitz EM, et al. (1998) Implementation of 3D-virtual brachytherapy in the management of breast cancer: a description of a new method of interstitial brachytherapy. Int J Radiat Oncol Biol Phys 40:629–635PubMedGoogle Scholar
  97. 97.
    Vicini FA, Kestin LL, Edmundson GK, et al. (1999) Dose-volume analysis for quality assurance of interstitial brachytherapy for breast cancer. Int J Radiat Oncol Biol Phys 45:803–810PubMedGoogle Scholar
  98. 98.
    Kestin LL, Jaffray DA, Edmundson GK, et al. (2000) Improving the dosimetric coverage of interstitial high-dose-rate breast implants. Int J Radiat Oncol Biol Phys 46:35–43PubMedCrossRefGoogle Scholar
  99. 99.
    Weed DW, Edmundson K, Vicini FA, et al. (2005) Accelerated partial breast irradiation: a dosimetric comparison of three different techniques. Brachytherapy 4:121–129PubMedCrossRefGoogle Scholar
  100. 100.
    Major T, Fodor J, Takácsi-Nagy Z, et al. (2005) Evaluation of HDR interstitial breast implants planned by conventional and optimized CT-based dosimetry systems with respect to dose homogeneity and conformality. Strahlenther Onkol 181:89–96PubMedCrossRefGoogle Scholar
  101. 101.
    Das RK, Patel R, Shah H, et al. (2004) 3D CT-based high-doserate breast brachytherapy implants: treatment planning and quality assurance. Int J Radiat Oncol Biol Phys 59:1224–1228PubMedCrossRefGoogle Scholar
  102. 102.
    Cuttino LW, Todor D, Arthur DW (2005) CT-guided multicatheter insertion technique for partial breast brachytherapy: reliable target coverage and dose homogeneity. Brachytherapy 4:10–17PubMedCrossRefGoogle Scholar
  103. 103.
    Major T, Fröhlich G, Lövey K, et al. (2009) Dosimetric experience with accelerated partial breast irradiation using image-guided interstitial brachytherapy. Radiother Oncol 90:48–55PubMedCrossRefGoogle Scholar
  104. 104.
    Kolotas C, Baltas D, Zamboglou N (1999) CT-based interstitial HDR brachytherapy. Strahlenther Onkol 175:419–427PubMedCrossRefGoogle Scholar

Copyright information

© Japan Society of Clinical Oncology 2009

Authors and Affiliations

  1. 1.Department of RadiotherapyNational Institute of OncologyBudapestHungary

Personalised recommendations

Cite article

Buy options